Sonidegib improved quality of life in patients with advanced basal cell carcinoma: results from the phase 2 Basal Cell Carcinoma Outcomes with LDE225 Treatment trial through 73 weeks - Archive ouverte HAL Access content directly
Journal Articles Journal of The American Academy of Dermatology Year : 2022

Sonidegib improved quality of life in patients with advanced basal cell carcinoma: results from the phase 2 Basal Cell Carcinoma Outcomes with LDE225 Treatment trial through 73 weeks

(1) , (2) , (3, 4) , (5, 6) , (7) , (8) , (8) , (9, 10)
1
2
3
4
5
6
7
8
9
10
Embargoed file
Embargoed file
Ne sera jamais visible

Dates and versions

inserm-03818996 , version 1 (18-10-2022)

Identifiers

Cite

Michael Migden, Carmen Loquai, Caroline Robert, Jean- François Baurain, Nicholas Squittieri, et al.. Sonidegib improved quality of life in patients with advanced basal cell carcinoma: results from the phase 2 Basal Cell Carcinoma Outcomes with LDE225 Treatment trial through 73 weeks. Journal of The American Academy of Dermatology, 2022, Online ahead of print. ⟨10.1016/j.jdin.2022.08.027⟩. ⟨inserm-03818996⟩
6 View
1 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More